A comprehensive review of AAV-mediated strategies targeting microglia for therapeutic intervention of neurodegenerative diseases
Journal of Neuroinflammation · 2024
DOI: 10.1186/s12974-024-03232-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neuroinflammation, 2024. Verfasst von Livia Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Henan Neurodevelopment Engineering Research Center for Children, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital Zh…. Hauptthemen laut MEDLINE: Microglia, Neurodegenerative Diseases, Dependovirus, Genetic Therapy. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Gothenburg.
Abstract (Originalsprache)
Neurodegenerative diseases pose a significant health burden globally, with limited treatment options available. Among the various cell types involved in the pathogenesis of these disorders, microglia, the resident immune cells of the central nervous system, play a pivotal role. Dysregulated microglial activation contributes to neuroinflammation and neuronal damage, making them an attractive target for therapeutic intervention. Adeno-associated virus (AAV) vectors have emerged as powerful tools for delivering therapeutic genes to specific cell types in the central nervous system with remarkable precision and safety. In the current review, we discuss the strategies employed to achieve selective transduction of microglia, including the use of cell-specific promoters, engineered capsids, and microRNA (miRNA) strategies. Additionally, we address the challenges and future directions in the development of AAV-based therapies targeting microglia. Overall, AAV-mediated targeting of microglia holds promise as a novel therapeutic approach for neurodegenerative diseases, offering the potential to modify disease progression and improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Henan Neurodevelopment Engineering Research Center for Children, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital Zhengzhou Children's Hospital, Zhengzhou, 450018, China. kaizhou5757@126…
- Henan Neurodevelopment Engineering Research Center for Children, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital Zhengzhou Children's Hospital, Zhengzhou, 450018, China.
- Henan Key Laboratory of Child Brain Injury and Henan Pediatric Clinical Research Center, Institute of Neuroscience and The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
- Henan Key Laboratory of Child Brain Injury and Henan Pediatric Clinical Research Center, Institute of Neuroscience and The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China. changlian.z…
- Center for Brain Repair and Rehabilitation, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden. changlian.zhu@neuro.gu.se.
Förderung
- University of Gothenburg
Zitieren
APA
Zhou, L., Wang, Y., Xu, Y., Zhang, Y., & Zhu, C. (2024). A comprehensive review of AAV-mediated strategies targeting microglia for therapeutic intervention of neurodegenerative diseases. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-024-03232-2
Vancouver
Zhou L, Wang Y, Xu Y, Zhang Y, Zhu C. A comprehensive review of AAV-mediated strategies targeting microglia for therapeutic intervention of neurodegenerative diseases. Journal of Neuroinflammation. 2024. doi:10.1186/s12974-024-03232-2
BibTeX
@article{Zhou2024,
author = {Zhou, Livia and Wang, Yafeng and Xu, Yiran and Zhang, Yaodong and Zhu, Changlian},
title = {A comprehensive review of AAV-mediated strategies targeting microglia for therapeutic intervention of neurodegenerative diseases},
journal = {Journal of Neuroinflammation},
year = {2024},
doi = {10.1186/s12974-024-03232-2}
}
EUVIMED